However, the cutoff for PD-L1 expression (clone 22C3) was chosen as ≥1% of a PD-L1-positive tumor or stromal cells based on studies from NSCLC and gastric cancer [14,15]. Here, CD274 is linked to non-small cell lung carcinoma.